HMGCR and metabolic dysfunction-associated steatotic liver disease: In the study performed by Min et al. [28], 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR) phosphorylation was decreased in NAFLD and NASH patients, indicating higher activity of this enzyme [42].